Guru Ownership Trend
Guru Analysis for Viridian Therapeutics, Inc. (VRDN)
Viridian Therapeutics, Inc. (VRDN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $115.29 M.
Top institutional holders include Steven Cohen and Ken Fisher.
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $50.29 M net inflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 625.8%. Conversely, Ken Fisher reduced exposure by 1.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Viridian Therapeutics, Inc. (VRDN)
Major holders include Steven Cohen ($43.04 M), Ken Fisher ($32.16 M), Renaissance Technologies (RenTech) ($14.12 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 5.05 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $50.29 M, with 4 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited VRDN. The total reported sell value was $320,464.64.
Yes, 1 managers opened new positions in VRDN, and 3 increased their existing holdings. The total reported buy value was $50.61 M.